KALA BIO, Inc. — Cash Flow Charts
16 quarters of history · ending 2022-12-31 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Capital Allocation Waterfall
Buybacks vs Stock-Based Comp
Net Debt Issuance
Cash Flow
Cash Flow by Activity
Operating Cash Flow↑+26.2% +$9M
$-24M
Free Cash Flow↑+26.2% +$9M
$-24M
Investing Cash Flow
$51K
Financing Cash Flow↑+19766.3% +$32M
$32M
Capex↑+166.7% +$340K
$544K
Stock-Based Comp↓-65.1% -$2M
$960K
Debt Issued
$0
D&A↓-62.3% -$132K
$80K
SBC Allocated Expense↓-65.1% -$2M
$960K